Form 4: Aura Biosciences CEO Elisabet de los Pinos Sells Shares to Cover Tax Obligations

Elisabet de los Pinos, CEO of Aura Biosciences, sold 20,221 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On February 18, 2025, Elisabet de los Pinos, the President and CEO of Aura Biosciences, sold 20,221 shares of common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $7.7541, with individual transactions ranging from $7.75 to $8.00.
• Following the transaction, de los Pinos directly owns 482,440 shares and indirectly owns 127,763 shares through the Elisabet de los Pinos Revocable Trust.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction (selling shares to cover taxes), so the sentiment is neutral. It's a standard practice and doesn't indicate any fundamental change in the company's prospects.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally viewed as routine transactions.

Stakeholder Impact

• The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

Keywords

Aura Biosciences, Elisabet de los Pinos, Stock Sale, Form 4, Insider Trading, Tax Obligations, Restricted Stock Units